Parvovirus B19 and the kidney

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue SUPPL. 1, 2007, Pages

  Waldman, Meryl ^a   Kopp, Jeffrey B ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; KIDNEY; KIDNEY DISEASE; PARVOVIRUS; REVIEW; VIROLOGY; VIRUS INFECTION;

HUMANS; KIDNEY; KIDNEY DISEASES; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 34748832780     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01060307     Document Type: Article

References (107)

1. Cossart YE, Field AM, Cant B, Widdows D: Parvovirus-like particles in human sera. Lancet 1: 72-73, 1975
2. Cossart Y: Parvovirus B19 finds a disease. Lancet 2: 988-989, 1981
3. Takahashi T, Ozawa K, Takahashi K, Asano S, Takaku F: Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood 75: 603-610, 1990
4. Ozawa K, Kurtzman G, Young N: Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood 70: 384-391, 1987
5. Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur G, Meritet JF, Garbarg-Chenon A: Genetic diversity within human erythroviruses: Identification of three genotypes. J Virol 76: 9124-9134, 2002
6. Hokynar K, Soderlund-Venermo M, Pesonen M, Ranki A, Kiviluoto O, Partio EK, Hedman K: A new parvovirus genotype persistent in human skin. Virology 302: 224-228, 2002
7. Nguyen QT, Sifer C, Schneider V, Allaume X, Servant A, Bernaudin F, Auguste V, Garbarg-Chenon A: Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol 37: 2483-2487, 1999
8. Cotmore SF, McKie VC, Anderson LJ, Astell CR, Tattersall P: Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J Virol 60: 548-557, 1986
9. Ozawa K, Young N: Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J Virol 61: 2627-2630, 1987
10. Rosenfeld SJ, Yoshimoto K, Kajigaya S, Anderson S, Young NS, Field A, Warrener P, Bansal G, Collett MS: Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J Clin Invest 89: 2023-2029, 1992
11. Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K: Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol 72: 3018-3028, 1998
12. Brown KE, Anderson SM, Young NS: Erythrocyte P antigen: Cellular receptor for B19 parvovirus. Science 262: 114-117, 1993
13. Moffatt S, Tanaka N, Tada K, Nose M, Nakamura M, Muraoka O, Hirano T, Sugamura K: A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol 70: 8485-8491, 1996
14. Kelly HA, Siebert D, Hammond R, Leydon J, Kiely P, Maskill W: The age-specific prevalence of human parvovirus immunity in Victoria, Australia, compared with other parts of the world. Epidemiol Infect 124: 449-457, 2000
15. Cohen BJ, Buckley MM: The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 25: 151-153, 1988
16. Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, Pattison JR, Tyrrell DA: Experimental parvoviral infection in humans. J Infect Dis 152: 257-265, 1985
17. Jordan JA: Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol 174: 37-42, 1996
18. Azzi A, Morfini M, Mannucci PM: The transfusion-associated transmission of parvovirus B19. Transfus Med Rev 13: 194-204, 1999
19. Heegaard ED, Laub Petersen B: Parvovirus B19 transmitted by bone marrow. Br J Haematol 111: 659-661, 2000
20. Broliden K: Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation. Pediatr Transplant 5: 320-330, 2001
21. Egbuna O, Zand MS, Arbini A, Menegus M, Taylor J: A cluster of parvovirus B19 infections in renal transplant recipients: A prospective case series and review of the literature. Am J Transplant 6: 225-231, 2006
22. Cooling LL, Koerner TA, Naides SJ: Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis 172: 1198-1205, 1995
23. Weigel-Kelley KA, Yoder MC, Srivastava A: Recombinant human parvovirus B19 vectors: Erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J Virol 75: 4110-4116, 2001
24. Weigel-Kelley KA, Yoder MC, Srivastava A: Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: Requirement of functional activation of beta1 integrin for viral entry. Blood 102: 3927-3933, 2003
25. Munakata Y, Saito-Ito T, Kumura-Ishii K, Huang J, Kodera T, Ishii T, Hirabayashi Y, Koyanagi Y, Sasaki T: Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 106: 3449-3456, 2005
26. Morita E, Nakashima A, Asao H, Sato H, Sugamura K: Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G(1) phase. J Virol 77: 2915-2921, 2003
27. Modrow S, Dorsch S: Antibody responses in parvovirus B19 infected patients. Pathol Biol (Paris) 50: 326-331, 2002
28. Saikawa T, Anderson S, Momoeda M, Kajigaya S, Young NS: Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol 67: 3004-3009, 1993
29. Lindblom A, Isa A, Norbeck O, Wolf S, Johansson B, Broliden K, Tolfvenstam T: Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis 41: 1201-1203, 2005
30. Soderlund-Venermo M, Hokynar K, Nieminen J, Rautakorpi H, Hedman K: Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris) 50: 307-316, 2002
31. Tolfvenstam T, Oxenius A, Price DA, Shacklett BL, Spiegel HM, Hedman K, Norbeck O, Levi M, Olsen K, Kantzanou M, Nixon DF, Broliden K, Klenerman P: Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19. J Virol 75: 540-543, 2001
32. Isa A, Kasprowicz V, Norbeck O, Loughry A, Jeffery K, Broliden K, Klenerman P, Tolfvenstam T, Bowness P: Prolonged activation of virus-specific CD8+T cells after acute B19 infection. PLoS Med 2: e343, 2005
33. Isa A, Norbeck O, Hirbod T, Lundqvist A, Kasprowicz V, Bowness P, Klenerman P, Broliden K, Tolfvenstam T: Aberrant cellular immune responses in humans infected persistently with parvovirus B19. J Med Virol 78: 129-133, 2006
34. Zhou S, Ou R, Huang L, Price GE, Moskophidis D: Differential tissue-specific regulation of antiviral CD8+ T-cell immune responses during chronic viral infection. J Virol 78: 3578-3600, 2004
35. Franssila R, Hokynar K, Hedman K: T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus b19. J Infect Dis 183: 805-809, 2001
36. von Poblotzki A, Gerdes C, Reischl U, Wolf H, Modrow S: Lymphoproliferative responses after infection with human parvovirus B19. J Virol 70: 7327-7330, 1996
37. Anderson LJ: Role of parvovirus B19 in human disease. Pediatr Infect Dis J 6: 711-718, 1987
38. Musiani M, Manaresi E, Gallinella G, Cricca M, Zerbini M: Recurrent erythema in patients with long-term parvovirus B19 infection. Clin Infect Dis 40: e117-e119, 2005
39. White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA: Human parvovirus arthropathy. Lancet 1: 419-421, 1985
40. Takahashi M, Ito M, Sakamoto F, Shimizu N, Furukawa T, Takahashi M, Matsunaga Y: Human parvovirus B19 infection: Immunohistochemical and electron microscopic studies of skin lesions. J Cutan Pathol 22: 168-172, 1995
41. Magro CM, Dawood MR, Crowson AN: The cutaneous manifestations of human parvovirus B19 infection. Hum Pathol 31: 488-497, 2000
42. Kerr JR, Cunniffe VS, Kelleher P, Coats AJ, Mattey DL: Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: Negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. J Med Virol 74: 147-155, 2004
43. Kerr JR, McCoy M, Burke B, Mattey DL, Pravica V, Hutchinson W: Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection. J Clin Pathol 56: 725-727, 2003
44. Serjeant GR, Serjeant BE, Thomas PW, Anderson MJ, Patou G, Pattison JR: Human parvovirus infection in homozygous sickle cell disease. Lancet 341: 1237-1240, 1993
45. Ergaz Z, Ornoy A: Parvovirus B19 in pregnancy. Reprod Toxicol 21: 421-435, 2006
46. Onguru P, Dede F, Bodur H, Ayli D, Akinci E, Cevik MA, Kilic A: Glomerulonephritis associating parvovirus B19 infection. Ren Fail 28: 85-88, 2006
47. Ieiri N, Hotta O, Taguma Y: Characteristics of acute glomerulonephritis associated with human parvovirus B19 infection. Clin Nephrol 64: 249-257, 2005
48. Ohtomo Y, Kawamura R, Kaneko K, Yamashiro Y, Kiyokawa N, Taguchi T, Mimori K, Fujimoto J: Nephrotic syndrome associated with human parvovirus B19 infection. Pediatr Nephrol 18: 280-282, 2003
49. Iwafuchi Y, Morita T, Kamimura A, Kunisada K, Ito K, Miyazaki S: Acute endocapillary proliferative glomerulonephritis associated with human parvovirus B19 infection. Clin Nephrol 57: 246-250, 2002
50. Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH, Jordan SC, Toyoda M: Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 59: 2126-2133, 2001
51. Komatsuda A, Ohtani H, Nimura T, Yamaguchi A, Wakui H, Imai H, Miura AB: Endocapillary proliferative glomerulonephritis in a patient with parvovirus B19 infection. Am J Kidney Dis 36: 851-854, 2000
52. Nakazawa T, Tomosugi N, Sakamoto K, Asaka M, Yuri T, Ishikawa I, Kitagawa S: Acute glomerulonephritis after human parvovirus B19 infection. Am J Kidney Dis 35: E31, 2000
53. Tanawattanacharoen S, Falk RJ, Jennette JC, Kopp JB: Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis 35: 1166-1174, 2000
54. Diaz F, Collazos J: Glomerulonephritis and Henoch-Schoenlein purpura associated with acute parvovirus B19 infection. Clin Nephrol 53: 237-238, 2000
55. Tolaymat A, Al Mousily F, MacWilliam K, Lammert N, Freeman B: Parvovirus glomerulonephritis in a patient with sickle cell disease. Pediatr Nephrol 13: 340-342, 1999
56. Murer L, Zacchello G, Bianchi D, Dall'Amico R, Montini G, Andreetta B, Perini M, Dossi EC, Zanon G, Zacchello F: Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol 11: 1132-1137, 2000
57. Bleumink GS, Halma C, van Vliet AC, de Jong GM, van Bommel EF: Human parvovirus B19 and renal disease. Neth J Med 56: 163-165, 2000
58. Mori Y, Yamashita H, Umeda Y, Uchiyama-Tanaka Y, Nose A, Kishimoto N, Kijima Y, Nagata T, Mori M, Matsubara H, Yoshida H, Iwasaka T: Association of parvovirus B19 infection with acute glomerulonephritis in healthy adults: Case report and review of the literature. Clin Nephrol 57: 69-73, 2002
59. Takeda S, Takaeda C, Takazakura E, Haratake J: Renal involvement induced by human parvovirus B19 infection. Nephron 89: 280-285, 2001
60. Taylor G, Drachenberg C, Faris-Young S: Renal involvement of human parvovirus B19 in an immunocompetent host. Clin Infect Dis 32: 167-169, 2001
61. Wierenga KJ, Pattison JR, Brink N, Griffiths M, Miller M, Shah DJ, Williams W, Serjeant BE, Serjeant GR: Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease. Lancet 346: 475-476, 1995
62. Seward EW, Rustom R, Nye FJ, Bone JM: Haemolyticuraemic syndrome following human parvovirus infection in a previously fit adult. Nephrol Dial Transplant 14: 2472-2473, 1999
63. Watanabe T, Oda Y: Henoch-Schonlein purpura nephritis associated with human parvovirus B19 infection. Pediatr Int 42: 94-96, 2000
64. Finkel TH, Torok TJ, Ferguson PJ, Durigon EL, Zaki SR, Leung DY, Harbeck RJ, Gelfand EW, Saulsbury FT, Hollister JR, et al.: Chronic parvovirus B19 infection and systemic necrotising vasculitis: Opportunistic infection or aetiological agent. Lancet 343: 1255-1258, 1994
65. Swaminathan S, Lager DJ, Qian X, Stegall MD, Larson TS, Griffin MD: Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants. Nephrol Dial Transplant 21: 2607-2614, 2006
66. Cassinotti P, Burtonboy G, Fopp M, Siegl G: Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 53: 229-232, 1997
67. Cassinotti P, Siegl G, Michel BA, Bruhlmann P: Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin. J Med Virol 56: 199-204, 1998
68. Liu JM, Green SW, Shimada T, Young NS: A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus. J Virol 66: 4686-4692, 1992
69. Moudgil A, Shidban H, Nast CC, Bagga A, Aswad S, Graham SL, Mendez R, Jordan SC: Parvovirus B19 infection-related complications in renal transplant recipients: Treatment with intravenous immunoglobulin. Transplantation 64: 1847-1850, 1997
70. Magro CM, Crowson AN, Dawood M, Nuovo GJ: Parvoviral infection of endothelial cells and its possible role in vasculitis and autoimmune diseases. J Rheumatol 29: 1227-1235, 2002
71. Kerr JR: Pathogenesis of parvovirus B19 infection: Host gene variability, and possible means and effects of virus persistence. J Vet Med B Infect Dis Vet Public Health 52: 335-339, 2005
72. Duranay M, Bali M, Sahin M, Yakinci G, Vurgun N, Dilmen U: Parvovirus B19 infection and unresponsiveness to erythropoietin therapy in haemodialysis patients. Nephrol Dial Transplant 13: 779-780, 1998
73. Arzouk N, Snanoudj R, Beauchamp-Nicoud A, Mourad G, Charpentier B, Tchernia G, Durrbach A: Parvovirus B19-induced anemia in renal transplantation: A role for rHuEPO in resistance to classical treatment. Transpl Int 19: 166-169, 2006
74. Ozeki M, Fukushima T, Ohzeki M, Sasaki T, Kashihara N: A nosocomial parvovirus B19 infection-induced transient aplastic crisis in a patient with chronic renal failure. Clin Nephrol 65: 141-143, 2006
75. Neild G, Anderson M, Hawes S, Colvin BT: Parvovirus infection after renal transplant. Lancet 2: 1226-1227, 1986
76. Bertoni E, Rosati A, Zanazzi M, Azzi A, Zakrzewska K, Guidi S, Fanci R, Salvadori M: Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: An underestimated infectious disease in the immunocompromised host. J Nephrol 10: 152-156, 1997
77. Marchand S, Tchernia G, Hiesse C, Tertian G, Cartron J, Kriaa F, Boubenider S, Goupy C, Lecointe D, Charpentier B: Human parvovirus B19 infection in organ transplant recipients. Clin Transplant 13: 17-24, 1999
78. Geetha D, Zachary JB, Baldado HM, Kronz JD, Kraus ES: Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: A case report and review of literature. Clin Transplant 14: 586-591, 2000
79. Eid AJ, Brown RA, Patel R, Razonable RR: Parvovirus B19 infection after transplantation: A review of 98 cases. Clin Infect Dis 43: 40-48, 2006
80. Ki CS, Kim IS, Kim JW, Lee NY, Kim SH, Lee KW, Kim SJ, Joh JW, Huh WS, Oh HY: Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients. Clin Transplant 19: 751-755, 2005
81. Zolnourian ZR, Curran MD, Rima BK, Coyle PV, O'Neill HJ, Middleton D: Parvovirus B19 in kidney transplant patients. Transplantation 69: 2198-2202, 2000
82. Yango A Jr, Morrissey P, Gohh R, Wahbeh A: Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction. Transpl Infect Dis 4: 163-166, 2002
83. Cavallo R, Merlino C, Re D, Bollero C, Bergallo M, Lembo D, Musso T, Leonardi G, Segoloni GP, Ponzi AN: B19 virus infection in renal transplant recipients. J Clin Virol 26: 361-368, 2003
84. Lee PC, Hung CJ, Lin YJ, Wang JR, Jan MS, Lei HY: A role for chronic parvovirus B19 infection in liver dysfunction in renal transplant recipients? Transplantation 73: 1635-1639, 2002
85. Shan YS, Lee PC, Wang JR, Tsai HP, Sung CM, Jin YT: Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipient. Nephrol Dial Transplant 16: 2420-2422, 2001
86. Laurenz M, Winkelmann B, Roigas J, Zimmering M, Querfeld U, Muller D: Severe parvovirus B19 encephalitis after renal transplantation. Pediatr Transplant 10: 978-981, 2006
87. Bilge I, Sadikoglu B, Emre S, Sirin A, Aydin K, Tatli B: Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient. Pediatr Nephrol 20: 529-533, 2005
88. Barsoum NR, Bunnapradist S, Mougdil A, Toyoda M, Vo A, Jordan SC: Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence. Am J Transplant 2: 425-428, 2002
89. Jordan JA: Diagnosing human parvovirus B19 infection: Guidelines for test selection. Mol Diagn 6: 307-312, 2001
90. Anderson LJ, Tsou C, Parker RA, Chorba TL, Wulff H, Tattersall P, Mortimer PP: Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol 24: 522-526, 1986
91. Peterlana D, Puccetti A, Corrocher R, Lunardi C: Serologic and molecular detection of human parvovirus B19 infection. Clin Chim Acta 372: 14-23, 2006
92. Lui SL, Luk WK, Cheung CY, Chan TM, Lai KN, Peiris JS: Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit. Transplantation 71: 59-64, 2001
93. Pamidi S, Friedman K, Kampalath B, Eshoa C, Hariharan S: Human parvovirus B19 infection presenting as persistent anemia in renal transplant recipients. Transplantation 69: 2666-2669, 2000
94. Shimmura H, Tanabe K, Ishikawa N, Tokumoto T, Toda F, Toma H: Discontinuation of immunosuppressive antimetabolite for parvovirus B19-associated anemia in kidney transplant patients. Transplant Proc 32: 1967-1970, 2000
95. Liefeldt L, Buhl M, Schweickert B, Engelmann E, Sezer O, Laschinski P, Preuschof L, Neumayer HH: Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy. Nephrol Dial Transplant 17: 1840-1842, 2002
96. Wong TY, Chan PK, Leung CB, Szeto CC, Tam JS, Li PK: Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Am J Kidney Dis 34: 1132-1136, 1999
97. Choi SH, Chang SP, Won JC, Lee JS, Chi HS, Yang WS, Park SK: A case of persistent anemia in a renal transplant recipient: Association with parvovirus B19 infection. Scand J Infect Dis 34: 71-75, 2002
98. Kerr JR: Pathogenesis of human parvovirus B19 in rheumatic disease. Am Rheum Dis 59: 672-683, 2000
99. Bock CT: Parvovirus B19: A new emerging pathogenic agent of inflammatory cardiomyopathy. Ernst Schering Res Found Workshop 83-97, 2006
100. Kuhl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP: Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112: 1965-1970, 2005
101. Diaz F, Collazos J: Hepatic dysfunction due to parvovirus B19 infection. J Infect Chemother 6: 63-64, 2000
102. So K, Macquillan G, Garas G, Delriviere L, Mitchell A, Speers D, Mews C, Augustson B, de Boer WB, Baker D, Jeffrey GP: Urgent liver transplantation for acute liver failure due to parvovirus B19 infection complicated by primary Epstein-Barr virus and cytomegalovirus infections and aplastic anaemia. Intern Med J 37: 192-195, 2007
103. Mustafa MM, McClain KL: Diverse hematologic effects of parvovirus B19 infection. Pediatr Clin North Am 43: 809-821, 1996
104. Aktepe OC, Yetgin S, Olcay L, Ozbek N: Human parvovirus B19 associated with idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 21: 421-426, 2004
105. Nigro G, Zerbini M, Krzysztofiak A, Gentilomi G, Porcaro MA, Mango T, Musiani M: Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet 343: 1260-1261, 1994
106. Barah F, Vallely PJ, Cleator GM, Kerr JR: Neurological manifestations of human parvovirus B19 infection. Rev Med Virol 13: 185-199, 2003
107. Magro CM, Wusirika R, Frambach GE, Nuovo GJ, Ferri C, Ross P Jr: Autoimmune-like pulmonary disease in association with parvovirus B19: A clinical, morphologic, and molecular study of 12 cases. Appl Immunohistochem Mol Morphol 14: 208-216, 2006